Question 1

Does Skandinaviska Enskilda Banken AB (publ) own RVMD stock?

Accepted Answer

No. Skandinaviska Enskilda Banken AB (publ) exited its RVMD (Revolution Medicines) position in Q3 2025. Its Q2 2025 13F listed 29,705 shares worth $1.1M.

Question 2

How many shares of RVMD does Skandinaviska Enskilda Banken AB (publ) own?

Accepted Answer

None since Q3 2025, when Skandinaviska Enskilda Banken AB (publ) exited the position. Its Q2 2025 13F listed 29,705 shares worth $1.1M.

Question 3

What is Skandinaviska Enskilda Banken AB (publ)'s RVMD position worth?

Accepted Answer

Skandinaviska Enskilda Banken AB (publ)'s RVMD position was worth $1.1M in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Skandinaviska Enskilda Banken AB (publ) buying or selling RVMD?

Accepted Answer

In Q3 2025, Skandinaviska Enskilda Banken AB (publ) exited its entire RVMD position.

Question 5

When did Skandinaviska Enskilda Banken AB (publ) first buy RVMD?

Accepted Answer

Skandinaviska Enskilda Banken AB (publ) first reported RVMD in its Q3 2023 13F and listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$46.07
2025-Q2	Unchanged	29,705	0.0%	$1.1M	0.0%	$36.91
2025-Q1	Unchanged	29,705	0.0%	$1.1M	0.0%	$37.35
2024-Q4	Unchanged	29,705	0.0%	$1.3M	0.0%	$43.17
2024-Q3	Unchanged	29,705	0.0%	$1.3M	0.0%	$44.17